FDA Prepares Prototypes Of Consumer Medical Information Options
This article was originally published in The Pink Sheet Daily
Workshop in September will gather input on how to ensure patients understand both risks and benefits.
You may also be interested in...
FDA appears poised to begin an overhaul of the dissemination of consumer drug information
FDA's Risk Communication Advisory Committee will meet Feb. 26-27 to discuss how to improve the usability of consumer medical information leaflets distributed by pharmacies with prescription drugs
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.